HORIZON-JU-GH-EDCTP3-2023-01-02
HORIZON-JU-GH-EDCTP3-2023-01-02
Programme: Horizon Europe
9 projects · €14,595,880 total EU contribution (project-level) · 49 participating organizations · 24 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€14,595,880
Countries active
Participant organizations by country (headquarters in CORDIS).
- Netherlands (5)
- UK (5)
- Germany (4)
- TZ (4)
- Spain (3)
- France (3)
- SE (3)
- BF (2)
- ET (2)
- MG (2)
- MZ (2)
- ZA (2)
- BJ (1)
- CD (1)
- CH (1)
- CI (1)
- GA (1)
- GH (1)
- IE (1)
- Italy (1)
- ML (1)
- NZ (1)
- SZ (1)
- UG (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- MAKERERE4 projects · UG
- ISGLOBAL3 projects · ES
- FM2 projects · MZ
- IRD2 projects · FR
- NIMR2 projects · TZ
- AIGHD Foundation2 projects · NL
- USTTB2 projects · ML
- ARMAUER HANSEN RESEARCH INSTITUTE1 projects · ET
- ANLRM1 projects · MZ
- PACCI1 projects · CI
- BAYLOR COLLEGE OF MEDICINE CHILDRENS FOUNDATION ESWATINI1 projects · SZ
- BNI1 projects · DE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
PREVENTING AND DELAYING THE DEVELOPMENT OF DIABETES IN AFRICA: A RANDOMISED PLACEBO -CONTROLLED DOUBLE-BLIND PHASE III TRIAL OF METFORMIN IN HIV-INFECTED PERSONS WITH PRE-DIABETES The META Trial · 101145764 | HORIZON | €1,811,068 | €0 | Details |
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV STOOL4TB · 101145812 | HORIZON | €348,248 | €7,500 | Details |
Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African children ASAAP-plus · 101145769 | HORIZON | €1,499,996 | €136,875 | Details |
Intensified tuberculosis treatment to reduce the high mortality of tuberculous meningitis in HIV-infected and uninfected patients INTENSE-TBM-2 · 101145712 | HORIZON | €2,497,565 | €119,000 | Details |
Fortifying the automated smartphone-based Cough Audio classification for rapid triaGE testing for tuberculosis project 4-CAGE-TB · 101145817 | HORIZON | €981,469 | €489,799 | Details |
Safety and efficacy of Dolutegravir and EFV400 for pregnant and breastfeeding women - a randomized non-inferiority clinical trial PREGART · 101145768 | HORIZON | €1,800,000 | €600,000 | Details |
PEP4LEP 2.0 - Chemoprohylaxis for leprosy: comparing the effectiveness and feasibility of a community-based intervention to a health centre-based intervention in Ethiopia, Mozambique, and Tanzania. PEP4LEP 2.0 · 101145677 | HORIZON | €1,780,304 | €65,900 | Details |
Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women - Extended PYRAPREG-extended · 101145638 | HORIZON | €1,539,645 | €346,000 | Details |
Randomised Controlled Trial of Preventive Treatment of Latent Tuberculosis Infection in Patients with Diabetes Mellitus PROTID · 101145612 | HORIZON | €2,337,586 | €0 | Details |